Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor

Annals of Surgical Oncology

Volumn 19, Issue 5, 2012, Pages 1628-1636

  Ariizumi, Shun Ichi ^a   Kotera, Yoshihito ^a   Katagiri, Satoshi ^a   Nakano, Masayuki ^b   Yamamoto, Masakazu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b Ofuna Chuo Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER CELL; CANCER CLASSIFICATION; CANCER RECURRENCE; CANCER STAGING; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; OVERALL SURVIVAL; PREOPERATIVE EVALUATION; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; CHOLANGIOCARCINOMA; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862545177     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2150-0     Document Type: Article

References (35)

1. Liver Cancer Study Group of Japan. Seventeenth nationwide survey of primary liver cancer in Japan. Kyoto, 2006.
2. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol. 1949;25:647-55.
3. Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Lyon: IARC, 2010.
4. Liver Cancer Study Group of Japan. General rules for the clinical and pathological study of primary liver cancer. 5th ed. Tokyo: Kanehara, 2008.
5. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular- cholangiocarcinoma: a histologic and immunohistochemical study. Cancer. 1985;55:124-35. (Pubitemid 15198209)
6. Nakamura S, Suzuki S, Sakaguchi T, et al. Surgical treatment of patients with mixed hepatocellular carcinoma and cholangiocarcinoma. Cancer. 1996;78:1671-6. (Pubitemid 26330894)
7. Taguchi J, Nakashima O, Tanaka M, et al. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol. 1996;11:758-64. (Pubitemid 26252907)
8. Ng IO, Shek TW, Nicholls J, et al. Combined hepatocellular cholangiocarcinoma: a clinicopathological study. J Gastroenterol Hepatol. 1998;13:34-40. (Pubitemid 28137756)
9. Jarnagin WR, Weber S, Tickoo SK, et al. Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factors. Cancer. 2002;94:2040-6. (Pubitemid 34270058)
10. Yano Y, Yamamoto J, Kosuge T, et al. Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected cases. Jpn J Clin Oncol. 2003;33:283-7. (Pubitemid 43115254)
11. Liu CL, Fan ST, Lo CM, et al. Hepatic resection for combined hepatocellular and cholangiocarcinoma. Arch Surg. 2003;138: 86-90.
12. Cazals-Hatem D, Rebouissou S, Bioulac-Stage P, et al. Clinical and molecular analysis of combined hepatocellular - cholangiocarcinomas. J Hepatol. 2004;41:292-8. (Pubitemid 39177634)
13. Koh KC, Lee H, Choi MS, et al. Clinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma. Am J Surg. 2005;189:120-5. (Pubitemid 40215518)
14. Lee WS, Lee KW, Heo JS, et al. Comparison of combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today. 2006;36:892-7.
15. Chantajitr S, Wilasrusmee C, Lertsitichai P, et al. Combined hepatocellular and cholangiocarcinoma;clinical features and prognostic study in a Thai population. J Hepatobiliary Pancreat Surg. 2006;13:537-42. (Pubitemid 46766710)
16. Zuo HQ, Yan LN, Zeng Y, et al. Clinicopathological characteristics of 15 patients with combined hepatocellular carcinoma and cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2007;6:161-5. (Pubitemid 46546995)
17. Lin G, Toh CH, Wu RC, et al. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Int J Clin Pract. 2007;62:1199-205. (Pubitemid 351977603)
18. Portolani N, Baiocchi GL, Coniglio A, et al. Intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma: a Western experience. Ann Surg Oncol. 2008;15:1880-90.
19. Shin CI, Lee JM, Kim SH, et al. Recurrence pattern of combined hepatocellular - cholangiocarcinoma on enhanced computed tomography. J Comput Assist Tomogr. 2007;31:109-15. (Pubitemid 46183349)
20. Kim KH, Lee SG, Park EH, et al. Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma. Ann Surg Oncol. 2009;16:623-9.
21. Wang J, Wang F, Kessinger A. Outcome of combined hepatocellular and cholangiocarcinoma of the liver. J Oncol. 2010;2010:917356.
22. Lee JH, Chung GE, Yu SJ, et al. Long-term prognosis of combined hepatocellular and cholangiocarcinoma after curative resection comparison with hepatocellular carcinoma and cholangiocarcinoma. J Clin Gastroenterol. 2011;45:69-75.
23. Aoki K, Takayasu K, Kawano T, et al. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings. Hepatology. 1993;18:1090-5. (Pubitemid 23320437)
24. Fukukura Y, Taguchi J, Nakashima O, et al. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr. 1997;21:52-8. (Pubitemid 27061156)
25. Sanada Y, Shiozaki S, Aoki H, et al. A clinical study of 11 cases of combined hepatocellular-cholangiocarcinoma. Assessment of enhancement pattern on dynamics computed tomography before resection. Hepatol Res. 2005;32:185-95. (Pubitemid 41070388)
26. Terminology Committee of the International Hepato-Pancreato-Biliary Association. The Brisbane 2000 terminology of liver anatomy and resections. HPB. 2000;2:333-9.
27. Sobin LH, Gospodarowics MK, Wittekind CH; International Union against Cancer. TNM classification of malignant tumours. 7th ed. UK: Wiley-Blackwell, 2009.
28. Panjala C, Senecal DL, Bridges MD, et al. The diagnostic conundrum and liver transplantation outcome for combined hepatocellular-cholangiocarcinoma. Am J Transplant. 2010;10:1263-7.
29. Maganty K, Levi D, Moon J, et al. Combined hepatocellular carcinoma and intrahepatic cholangiocarcinoma: outcome after liver transplantation. Dig Dis Sci. 2010;55:3597-601.
30. Sapisochin G, Fidelman N, Roberts JP, et al. Mixed hepatocellular- cholangiocarcinoma (HCC-CC) and intra-hepatic cholangiocarcinoma (I-CC) in patients transplanted for hepatocellular carcinoma. Liver Transpl. 2011;17:934-42.
31. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incident cholangiocarcinoma. Liver Transpl. 2005;11:1412-6.
32. Kim JH, Yoon HK, Ko GY, et al. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization. Radiology. 2010;255:270-7.
33. Theise ND, Yao JL, Harada K, et al. Hepatic "stem cell"malignancies in adults: four cases. Histopathology. 2003;43:263-71. (Pubitemid 37115060)
34. Zhang F, Chen XP, Zhang W, et al. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence. Histopathology. 2008;52:224-32.
35. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Switzerland: WHO Press, 2010.